
The FDA accepted uniQure's biologics license application for ifezuntirgene inilparvovec and granted it Priority Review, setting a target action date of May 1, 2027.
Is the parkinsonian phenotype seen in welders related to the exposure of manganese-containing welding fumes?
Is the parkinsonian phenotype seen in welders related to the exposure of manganese-containing welding fumes?
The results, published in
Progression of parkinsonism increased with cumulative manganese exposure. Exposure was clinically associated with upper limb bradykinesia, upper and lower limb rigidity, and clinical dysfunction of speech and facial expression.